Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease - Concepedia

Concepedia

Publication | Closed Access

Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease

20

Citations

18

References

2009

Year

Stanley M. Belkowski, J. D. Boot, Mary Ann Mascelli, Zuzana Diamant, Lawrence de Garavilla, Brenda Hertzog, Deborah A. Polkovitch, Marcia Towers, Ameesha Batheja, M. R. D’Andrea

Clinical & Experimental Allergy

Abstract

Our data indicate that cSLPI reflects chymase activity in AR and asthma. Hence, cSLPI may serve as a biomarker for disease activity and for monitoring the efficacy of novel anti-inflammatory treatments in chymase-mediated diseases.

References

	Year	Citations

Page 1